期刊论文详细信息
Rheumatology and Therapy | 卷:6 |
A Summary of 2018 and What Lies Ahead for Rheumatology and Therapy in 2019 | |
Roy Fleischmann1  | |
[1] Metroplex Clinical Research Center, University of Texas Southwestern Medical Center; | |
关键词: Biosimilars; Gout; JAK inhibitors; Osteoarthritis; Psoriatic arthritis; Rheumatoid arthritis; | |
DOI : 10.1007/s40744-018-0136-0 | |
来源: DOAJ |
【 摘 要 】
【 授权许可】
Unknown